DK0712389T3 - Terapeutisk forbindelse - fedtsyrekonjugater - Google Patents
Terapeutisk forbindelse - fedtsyrekonjugaterInfo
- Publication number
- DK0712389T3 DK0712389T3 DK94922189T DK94922189T DK0712389T3 DK 0712389 T3 DK0712389 T3 DK 0712389T3 DK 94922189 T DK94922189 T DK 94922189T DK 94922189 T DK94922189 T DK 94922189T DK 0712389 T3 DK0712389 T3 DK 0712389T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic compound
- fatty acid
- therapeutic
- acid conjugates
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Steroid Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPM032593 | 1993-08-02 | ||
| PCT/AU1994/000440 WO1995004030A1 (en) | 1993-08-02 | 1994-08-02 | Therapeutic compound - fatty acid conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0712389T3 true DK0712389T3 (da) | 2001-06-05 |
Family
ID=3777106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94922189T DK0712389T3 (da) | 1993-08-02 | 1994-08-02 | Terapeutisk forbindelse - fedtsyrekonjugater |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5792786A (da) |
| EP (1) | EP0712389B1 (da) |
| JP (1) | JPH09501655A (da) |
| CN (1) | CN1125040C (da) |
| AT (1) | ATE198880T1 (da) |
| CA (1) | CA2167818A1 (da) |
| DE (1) | DE69426629T2 (da) |
| DK (1) | DK0712389T3 (da) |
| ES (1) | ES2156156T3 (da) |
| FI (1) | FI960504A0 (da) |
| NO (1) | NO313227B1 (da) |
| NZ (1) | NZ269773A (da) |
| RU (1) | RU2137755C1 (da) |
| WO (1) | WO1995004030A1 (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM747694A0 (en) * | 1994-08-16 | 1994-09-08 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids and peptides |
| EP0804459A4 (en) * | 1995-01-16 | 1999-05-26 | Commw Scient Ind Res Org | CONJUGATES THERAPEUTIC COMPOUND - FATTY ACID |
| DE69633009T2 (de) * | 1995-05-01 | 2005-07-21 | Scarista Ltd., Douglas | Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen |
| MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
| USRE40546E1 (en) * | 1996-05-01 | 2008-10-21 | Scarista, Ltd. | 1,3-Propane diol esters and ethers and methods for their use in drug delivery |
| AUPN741696A0 (en) * | 1996-01-05 | 1996-01-25 | Commonwealth Scientific And Industrial Research Organisation | Delivery of nucleic acids ii |
| DE19631189A1 (de) * | 1996-08-02 | 1998-02-05 | Max Delbrueck Centrum | Neuartige kationische Amphiphile für den liposomalen Gentransfer |
| AUPP751398A0 (en) * | 1998-12-04 | 1999-01-07 | Commonwealth Scientific And Industrial Research Organisation | Methotrexate derivatives |
| US6207700B1 (en) | 1999-01-07 | 2001-03-27 | Vanderbilt University | Amide derivatives for antiangiogenic and/or antitumorigenic use |
| US6762182B1 (en) | 1999-01-07 | 2004-07-13 | Vanderbilt University | Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| US6716452B1 (en) * | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US6306890B1 (en) | 1999-08-30 | 2001-10-23 | Vanderbilt University | Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors |
| US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
| AR034362A1 (es) * | 2001-06-05 | 2004-02-18 | Control Delivery Systems | Compuestos analgesicos de liberacion prolongada |
| US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
| US20060014697A1 (en) | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
| US20030148379A1 (en) * | 2002-02-06 | 2003-08-07 | Roitman Daniel B. | Methods for making microbar encoders for bioprobes |
| SI1644019T2 (en) * | 2003-05-29 | 2018-04-30 | Shire Llc | AMPHETAMINE COMPOUNDS COMPOUNDS TO ABUSE |
| WO2005112921A2 (en) | 2004-04-26 | 2005-12-01 | Vanderbilt University | Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity |
| DE602005017177D1 (de) | 2004-07-05 | 2009-11-26 | Ziscoat N V | Biokompatible beschichtung von medizinischen vorrichtungen mit molekularsieben |
| US7691364B2 (en) * | 2005-01-28 | 2010-04-06 | Bezwada Biomedical, Llc | Functionalized drugs and polymers derived therefrom |
| EP2322183B1 (en) * | 2006-06-01 | 2014-10-22 | Santen SAS | Use of prodrugs for ocular intravitreous administration |
| WO2007149456A2 (en) | 2006-06-19 | 2007-12-27 | Vanderbilt University | Methods and compositions for diagnostic and therapeutic targeting of cox-2 |
| CN108250090B (zh) * | 2006-07-27 | 2021-08-20 | 于崇曦 | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 |
| EP2813486B1 (en) | 2008-07-08 | 2017-10-25 | Catabasis Pharmaceuticals, Inc. | Fatty acid acetylated salicylates and their uses |
| US9085527B2 (en) | 2008-07-08 | 2015-07-21 | Catabasis Pharmaceuticals, Inc. | Fatty acid acylated salicylates and their uses |
| US9346803B2 (en) | 2011-10-17 | 2016-05-24 | Vanderbilt University | Indomethacin analogs for the treatment of castrate-resistant prostate cancer |
| EP2863921B1 (en) * | 2012-06-26 | 2018-04-18 | Polyactiva Pty Ltd | Polymer-nsaid conjugate |
| CA2972871A1 (en) * | 2015-01-23 | 2016-07-28 | Novartis Ag | Synthetic apelin fatty acid conjugates with improved half-life |
| WO2024018762A1 (ja) * | 2022-07-19 | 2024-01-25 | 国立大学法人北海道大学 | ｐＨ感受性カチオン性脂質及び脂質ナノ粒子 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3686238A (en) * | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| BE871709A (fr) * | 1978-10-31 | 1979-02-15 | Abbott Lab | Procede de preparation de composes doues d'une activite anti-inflammatoire |
| DE3904119A1 (de) | 1989-02-11 | 1990-08-16 | Hoechst Ag | Polymerfixiertes methotrexat, verfahren zur herstellung und verwendung |
| DK0506748T3 (da) * | 1989-12-22 | 1996-01-22 | Commw Scient Ind Res Org | Aminosyrer, peptider eller derivater deraf bundet til fedtstoffer |
| EP0576605A4 (en) | 1991-03-19 | 1994-06-08 | Vithal J Rajadhyaksha | Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers |
| EP0596959B1 (en) * | 1991-07-26 | 2000-03-29 | Commonwealth Scientific And Industrial Research Organisation | Self-adjuvanting peptide vaccine delivery system and production thereof |
| DE4311987A1 (de) | 1993-04-07 | 1994-10-13 | Schering Ag | Neue Glucocorticoide |
-
1994
- 1994-08-02 JP JP7505456A patent/JPH09501655A/ja active Pending
- 1994-08-02 CA CA002167818A patent/CA2167818A1/en not_active Abandoned
- 1994-08-02 CN CN94192985A patent/CN1125040C/zh not_active Expired - Fee Related
- 1994-08-02 ES ES94922189T patent/ES2156156T3/es not_active Expired - Lifetime
- 1994-08-02 WO PCT/AU1994/000440 patent/WO1995004030A1/en active IP Right Grant
- 1994-08-02 EP EP94922189A patent/EP0712389B1/en not_active Expired - Lifetime
- 1994-08-02 DK DK94922189T patent/DK0712389T3/da active
- 1994-08-02 AT AT94922189T patent/ATE198880T1/de not_active IP Right Cessation
- 1994-08-02 NZ NZ269773A patent/NZ269773A/en unknown
- 1994-08-02 DE DE69426629T patent/DE69426629T2/de not_active Expired - Fee Related
- 1994-08-02 US US08/592,399 patent/US5792786A/en not_active Expired - Fee Related
- 1994-08-02 RU RU96104379A patent/RU2137755C1/ru not_active IP Right Cessation
-
1996
- 1996-01-30 NO NO19960389A patent/NO313227B1/no not_active IP Right Cessation
- 1996-02-02 FI FI960504A patent/FI960504A0/fi not_active IP Right Cessation
-
1998
- 1998-01-30 US US09/016,633 patent/US6353124B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO960389D0 (no) | 1996-01-30 |
| US6353124B1 (en) | 2002-03-05 |
| WO1995004030A1 (en) | 1995-02-09 |
| NZ269773A (en) | 1997-11-24 |
| NO313227B1 (no) | 2002-09-02 |
| EP0712389B1 (en) | 2001-01-24 |
| EP0712389A1 (en) | 1996-05-22 |
| NO960389L (no) | 1996-01-30 |
| ATE198880T1 (de) | 2001-02-15 |
| US5792786A (en) | 1998-08-11 |
| DE69426629D1 (de) | 2001-03-01 |
| FI960504A (fi) | 1996-02-02 |
| JPH09501655A (ja) | 1997-02-18 |
| CA2167818A1 (en) | 1995-02-09 |
| ES2156156T3 (es) | 2001-06-16 |
| CN1125040C (zh) | 2003-10-22 |
| RU2137755C1 (ru) | 1999-09-20 |
| EP0712389A4 (en) | 1997-04-09 |
| DE69426629T2 (de) | 2001-08-02 |
| CN1128531A (zh) | 1996-08-07 |
| FI960504A0 (fi) | 1996-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0712389T3 (da) | Terapeutisk forbindelse - fedtsyrekonjugater | |
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| DE69409969D1 (de) | Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen | |
| BR9607492A (pt) | Conjugados de ácidos graxos de composto terapêutico | |
| BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
| IS4695A (is) | (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem sýklóoxýgenasa-2 tálmar | |
| PA8452001A1 (es) | Derivados de macrolidos c-4" sustituidos | |
| MX9403570A (es) | Conjugados de farmaco-ligando, proceso para su preparacion y composicionesfarmaceuticas que los incluyen. | |
| EA199901063A1 (ru) | Пиперазиновые производные и их применение в качестве противовоспалительных агентов | |
| DE69616749D1 (de) | Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe | |
| NO975035D0 (no) | Fettsyreestere som bioaktive forbindelser | |
| PT753301E (pt) | Combinacao de um benzimidazole tendo actividade antagonista da angiotensina ii com um diuretico | |
| LV12291A (lv) | Savienojums un farmaceitiskas kompozicijas ar triptazes aktivitates izmainam saistitu slimibu arstesanai | |
| ES2081178T3 (es) | Compuestos anti-tumorales que contienen anillos quinazolina y tetrazol. | |
| ES2148593T3 (es) | Compuestos retinoides trienoicos novedosos y metodos. | |
| PT1023267E (pt) | Compostos de piridilo e composicoes farmaceuticas que os contem | |
| ES2033985T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica. | |
| GT199700037A (es) | Composiciones farmaceuticas para el tratamiento de la rinitis | |
| ES2142030T3 (es) | Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2136252T3 (es) | Tratamiento de enfermedades causadas por trastornos de la glandula sebacea mediante el uso de inhibidores de acil coa colesterol acil transferasa. | |
| ES2069915T3 (es) | Dicarbonatos y uretanos de los acidos 4,5-dihidroxi- y 4,5,8-trihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilicos que tienen actividades terapeuticas. | |
| DE69518073T2 (de) | Pyrazol-Carbonsäurederivate als Mittel zur Bekämpfung von Pflanzenkrankheiten | |
| ES2148458T3 (es) | Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2118650T3 (es) | Derivados de la quinolina-4-carbonilguanidina, procedimiento para la preparacion de los mismos y preparaciones farmaceuticas que contienen los compuestos. |